Sleepiness and Depression in Parkinson's Disease Patients Treated with Ropinirole and Levodopa
Journal of Movement Disorders
;
: 123-129, 2017.
Artigo
em Inglês
| WPRIM
| ID: wpr-90986
ABSTRACT
OBJECTIVE:
We aimed to investigate the effect of ropinirole on excessive daytime sleepiness (EDS) and depression in Parkinson’s disease (PD) with a large population.METHODS:
We conducted a cross-sectional observational study at nine hospitals in Korea between April 24, 2013, and April 22, 2015. We analyzed the demographic and clinical features, other medical history, history of antiparkinsonian medication within 6 months, Hoehn and Yahr stage (HY stage), Unified Parkinson’s Disease Rating Scale (UPDRS) part II and III, Epworth Sleepiness Scale (ESS), and 30-item Geriatric Depression Scale (GDS-30).RESULTS:
Four-hundred-thirteen patients with PD (mean age 65.2 ± 9.0 years; men 227 patients) were analyzed. Multivariate logistic regression analysis showed that age at examination, UPDRS II, and GDS-30 were independent risk factors for EDS and that sex, UPDRS II, and ESS were independent risk factors for depression.CONCLUSION:
Our large group study did not find any significant associations of ropinirole with EDS and depression in Korean PD patients.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Doença de Parkinson
/
Levodopa
/
Modelos Logísticos
/
Fatores de Risco
/
Depressão
/
Estudo Observacional
/
Coreia (Geográfico)
Tipo de estudo:
Estudo de etiologia
/
Estudo observacional
/
Estudo prognóstico
/
Fatores de risco
Limite:
Humanos
/
Masculino
País/Região como assunto:
Ásia
Idioma:
Inglês
Revista:
Journal of Movement Disorders
Ano de publicação:
2017
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS